Drug Screening Kits-OCME-FY11-Goods-RFQ

The District of Columbia Office of Contracting and Procurement is seeking to establish a Blanket Purchase Agreement (BPA) for toxicology kits to support the Office of the Chief Medical Examiner (OCME). This procurement is specifically for drug screening kits to be acquired on an as-needed basis, targeting laboratory and forensic testing requirements. The solicitation was initially posted on November 23, 2010, with a proposal submission deadline of November 29, 2010, indicating a very tight turnaround for potential vendors. The contract appears focused on providing specialized diagnostic kits that will enable OCME to conduct comprehensive toxicological screenings and analyses. While specific technical specifications are not detailed in the provided information, the procurement suggests a need for high-quality, reliable drug screening equipment that meets forensic and medical examination standards.

The contract opportunity does not explicitly outline specific set-aside designations or vendor restrictions based on the available information. No incumbent vendors or current contractors are identified in the documentation. The procurement appears to be a standard goods acquisition for a government agency, potentially open to various qualified medical and laboratory supply vendors. Without definitive budget range information, the scale of the BPA remains unclear, though the term "as-needed basis" implies flexibility in ordering and potential variable spending. The solicitation's brevity suggests that interested vendors would need to contact the D.C. Office of Contracting and Procurement directly for more comprehensive details about qualification requirements, evaluation criteria, and potential contract value.